Literature DB >> 22926943

Searching for Hif1-α interacting proteins in renal cell carcinoma.

V Medina Villaamil1, G Aparicio Gallego, I Santamarina Caínzos, M Valladares-Ayerbes, L M Antón Aparicio.   

Abstract

INTRODUCTION: Kidney tumours are frequently characterised by hypoxic conditions due to a local imbalance between oxygen (O2) supply and consumption. Hif1-α regulates angiogenesis, tumour growth, tumour progression, metastatic spread, and glucose metabolism by acting as a transcription factor for relevant genes. Here, we describe an immunohistochemical study of Hif1-α, a comprehensive computational study of Hif1-α interacting proteins (HIPs), an analysis correlating expression levels of Hif1-α with upstream and downstream proteins, and an analysis of the utility of Hif1-α for prognosis in a cohort of patients with renal cell carcinoma.
MATERIALS AND METHODS: The patient cohort included 80 patients. For immunohistochemistry evaluation, tissue microarrays were constructed. The IntAct, MINT, and BOND databases were used for the HIP approach. The Kruskal-Wallis test was used for comparing protein expression with pathology measurements. Correlation was expressed as the Pearson coefficient.
RESULTS: Hif1-α expression correlates significantly with the "clear" histological subtype of renal cell carcinoma (p < 0.01). The samples with the worst prognoses related to the pathological variables analysed showed the highest levels of Hif1-α expression. Significant correlations were found with Bcl-2, CAIX, C-kit, EGFR, TGF-β, proteins of the VEGF family, proteins related to differentiation (such as Notch1 and Notch3) and certain metabolic enzymes. Bioinformatic analysis suggested 45 evidence-based HIPs and 4 complexes involving protein Hif1-α.
CONCLUSIONS: This work summarises the multifaceted role of Hif1-α in the pathology of renal cell carcinomas, and it identifies HIPs that could help provide mechanistic explanations for the different behaviours seen in tumours.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926943     DOI: 10.1007/s12094-012-0857-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  39 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Authors:  H Zhong; K Chiles; D Feldser; E Laughner; C Hanrahan; M M Georgescu; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

3.  Fructose transporter GLUT5 expression in clear renal cell carcinoma.

Authors:  V Medina Villaamil; G Aparicio Gallego; L Valbuena Rubira; R García Campelo; M Valladares-Ayerbes; E Grande Pulido; M Victoria Bolós; I Santamarina Caínzos; L M Antón Aparicio
Journal:  Oncol Rep       Date:  2010-12-10       Impact factor: 3.906

4.  [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance].

Authors:  Peng Lin; Wei Wang; Wen-juan Cai; Chun-rong Han; Yan Sun; Man Li; Bao-cun Sun
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2009-06

Review 5.  [Tumor hypoxia: the role of HIF].

Authors:  Avelino Fraga; Ricardo Ribeiro; Rui Medeiros
Journal:  Actas Urol Esp       Date:  2009-10       Impact factor: 0.994

6.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion.

Authors:  Cecilia Sahlgren; Maria V Gustafsson; Shaobo Jin; Lorenz Poellinger; Urban Lendahl
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

7.  MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.

Authors:  Sirigiri Divijendra Natha Reddy; Suresh B Pakala; Kazufumi Ohshiro; Suresh K Rayala; Rakesh Kumar
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

8.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

Review 9.  Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

Authors:  Allan J Pantuck; Gang Zeng; Arie S Belldegrun; Robert A Figlin
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

10.  miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

Authors:  E J Noonan; R F Place; D Pookot; S Basak; J M Whitson; H Hirata; C Giardina; R Dahiya
Journal:  Oncogene       Date:  2009-03-02       Impact factor: 9.867

View more
  6 in total

1.  IL-37 mediates the antitumor activity in renal cell carcinoma.

Authors:  Yazhuo Jiang; Yili Wang; Liang Liang; Yang Gao; Juan Chen; Yi Sun; Yongyi Cheng; Yonggang Xu
Journal:  Med Oncol       Date:  2015-10-13       Impact factor: 3.064

2.  Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis.

Authors:  Leiping Fu; Gang Wang; Maria M Shevchuk; David M Nanus; Lorraine J Gudas
Journal:  Cancer Res       Date:  2013-02-27       Impact factor: 12.701

Review 3.  The role of HIF1α in renal cell carcinoma tumorigenesis.

Authors:  Lorraine J Gudas; Leiping Fu; Denise R Minton; Nigel P Mongan; David M Nanus
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

4.  WSB1 promotes tumor metastasis by inducing pVHL degradation.

Authors:  Jung Jin Kim; Seung Baek Lee; Jinsung Jang; Sang-Yeop Yi; Sun-Hyun Kim; Sang-Ah Han; Jong-Min Lee; Seo-Yun Tong; Nicole D Vincelette; Bowen Gao; Ping Yin; Debra Evans; Dong Wook Choi; Bo Qin; Tongzheng Liu; Haoxing Zhang; Min Deng; Jin Jen; Jun Zhang; Liewei Wang; Zhenkun Lou
Journal:  Genes Dev       Date:  2015-11-01       Impact factor: 11.361

Review 5.  Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma.

Authors:  Ilaria Marech; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Int J Mol Sci       Date:  2014-07-23       Impact factor: 5.923

Review 6.  Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.

Authors:  Girolamo Ranieri; Ilaria Marech; Artor Niccoli Asabella; Alessandra Di Palo; Mariangela Porcelli; Valentina Lavelli; Giuseppe Rubini; Cristina Ferrari; Cosmo Damiano Gadaleta
Journal:  Int J Mol Sci       Date:  2017-09-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.